Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33:1387–98.CrossRefPubMed
2.
Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73–92.CrossRefPubMed
3.
Langsteger W, Beheshti M, Poecher S, Loidl W, Haim S, Stoiber F, et al. Fluor choline (FCH) positron emission tomography/computed tomography in preoperative staging and follow up of prostate cancer patients. Mol Imag Biol 2006;8(2):69.
4.
Beheshti M, Haim S, Nader M, Poecher S, Jordanova N, Stoiber F, et al. Assessment of bone metastases in patients with prostate cancer by dual-phase F-18 fluor choline PET/CT. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:208.
5.
Langsteger W, Beheshti M, Nader M, Stoiber F, Loidl W, Fitz F, et al. Evaluation of lymph node and bone metastases with fluor choline (FCH) PET-CT in the follow up of prostate cancer patients. Eur J Nucl Med Mol Imaging 2006;33 Suppl 2:209.
Metadata
Title
[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer
Authors
Mohsen Beheshti
Reza Vali
Werner Langsteger
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0401-x

Other articles of this Issue 8/2007

European Journal of Nuclear Medicine and Molecular Imaging 8/2007 Go to the issue

Original article

Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

Original Article

Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy

Image of the month

PET/CT demonstrates increased myocardial FDG uptake following irradiation therapy

White paper

White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging

Original Article

Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET

Original article

Assessment of coronary flow reserve by sestamibi imaging in patients with typical chest pain and normal coronary arteries